Ranok Therapeutics reports positive Phase 1a clinical results for KRAS G12D inhibitor RNK08954
Innovent's IBI363 receives third Chinese regulatory BTD for MSS/pMMR CRC
European Commission approves Bristol Myers Squibb's Sotyktu for psoriatic arthritis
Chance Pharma reports NMPA acceptance of NDA for investigational respiratory drug CXG87
Racura Oncology identifies mechanism of action for (E,E)-bisantrene
Xcovery and EVERSANA partner for US commmercialisation of lung cancer drug Ensacove
Cipla's AB-rated Ventolin HFA generic receives US FDA approval
Orion Pharma launches Phase 1b/2 TEADCO trial of ODM-212 in advanced solid tumours
Natera showcases Prospera transplant data across 17 presentations at ISHLT 2026